GLP-1 Agonists and Alzheimer's Prevention: What the Evidence Shows in 2026
Semaglutide and tirzepatide do more than control weight. Here's what the clinical evidence shows about GLP-1 agonists for cognitive protection and Alzheimer's risk reduction.
Longevity Medicine
Cognitive Protection
GLP-1 Agonists and Alzheimer's Prevention: What the Evidence Shows in 2026. Part of the Longevity Medicine library by Julian Douwes, M.D.
